Impact of Dietary Lipids on Colonic Function and Microbiota: An Experimental Approach Involving Orlistat-Induced Fat Malabsorption in Human Volunteers
Author
dc.contributor.author
Morales, Pamela
Author
dc.contributor.author
Fujio, Sayaka
Author
dc.contributor.author
Navarrete Wallace, Paola
Author
dc.contributor.author
Ugalde, Juan
Author
dc.contributor.author
Magne, Fabien
Author
dc.contributor.author
Carrasco Pozo, Catalina
Author
dc.contributor.author
Tralma, Karina
Author
dc.contributor.author
Quezada, María Paz
Author
dc.contributor.author
Hurtado Heim, Carmen
Author
dc.contributor.author
Natalia Covarrubias, Natalia
Author
dc.contributor.author
Brignardello, Jerusa
Author
dc.contributor.author
Henríquez, Daniela
Author
dc.contributor.author
Gotteland, Martín
Admission date
dc.date.accessioned
2016-10-18T16:00:40Z
Available date
dc.date.available
2016-10-18T16:00:40Z
Publication date
dc.date.issued
2016
Cita de ítem
dc.identifier.citation
Clinical and Translational Gastroenterology (2016) 7, e161
es_ES
Identifier
dc.identifier.other
10.1038/ctg.2016.20
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/140843
Abstract
dc.description.abstract
OBJECTIVES: High-fat diets alter gut microbiota and barrier function, inducing metabolic endotoxemia and low-grade
inflammation. Whether these effects are due to the high dietary lipid content or to the concomitant decrease of carbohydrate intake
is unclear. The aim of this study was to determine whether higher amounts of dietary fat reaching the colon (through orlistat
administration) affect the colonic ecosystem in healthy volunteers and the effect of the prebiotic oligofructose (OF) in this model.
METHODS: Forty-one healthy young subjects were distributed among four groups: Control (C), Prebiotic (P), Orlistat (O), and
Orlistat/Prebiotic (OP). They consumed a fat-standardized diet (60 g/day) during Week-1 (baseline) and after 1 week of washout,
Week-3. During Week-3, they also received their respective treatment (Orlistat: 2 × 120 mg/day, OF: 16 g/day, and maltodextrin as
placebo). A 72-h stool collection was carried out at the end of Week-1 (T0) and Week-3 (T1). Fecal fat, calprotectin, and short-chain
fatty acids (SCFAs) as well as the antioxidant activity of fecal waters (ferric-reducing antioxidant power), fecal microbiota
composition (by deep sequencing), and gut permeability (Sucralose/Lactulose/Mannitol test) were determined at these times.
RESULTS: Fecal fat excretion was higher in the O (P=0.0050) and OP (P=0.0069) groups. This event was accompanied, in the O
group, by an increased calprotectin content (P=0.047) and a decreased fecal antioxidant activity (P=0.047). However, these
alterations did not alter gut barrier function and the changes observed in the composition of the fecal microbiota only affected
bacterial populations with low relative abundance (o0.01%); in consequences, fecal SCFA remained mainly unchanged. Part of
the colonic alterations induced by orlistat were prevented by OF administration.
CONCLUSIONS: In the context of an equilibrated diet, the acute exposition of the colonic ecosystem to high amounts of dietary
lipids is associated with an incremented excretion of fecal calprotectin and pro-oxidant activity of the colonic content, in the
absence of significant changes in the microbiota.
es_ES
Patrocinador
dc.description.sponsorship
FONDECYT from CONICYT Chile
1080519
1120290
11140666